Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Muscle-invasive Urothelial Cancer of the Bladder × Transurethral Resection of Bladder × Genitourinary × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 12 Urothelial Carcinoma of the Bladder 1 Prostatic Hyperplasia 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Muscle-invasive Urothelial Cancer of the Bladder 1

Interventions

pembrolizumab 1 Transurethral Resection of Bladder 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02621151 2025-10-07

Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder

NYU Langone Health

Phase 2 Active not recruiting

60 enrolled 11 charts

Muscle-invasive Urothelial Cancer of the Bladder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡